For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP433

2462

Dr.Shwetha G R
Membership No Author Name Email Mobile
2462 Dr.Shwetha G R shwetha.gr.hims@gmail.com 9916458192
Surgical Retina

PREOPERATIVE 0.1% BRIMONIDINE FOR  HEMOSTASIS IN DIABETIC VITRECTOMY- A RANDOMISED CONTROLLED TRIAL

Purpose-
To evaluate efficacy of preoperative 0.1% Brimonidine in improving intraoperative hemostasis during Diabetic vitrectomy. 
Methods- 
Patients undergoing vitrectomy were allocated to 4 groups: Group A, preoperative 0.5% CMC drops; Group B, preoperative 0.1% Brimonidine drops; Group C, preoperative  antiVEGF; Group D, both antiVEGF and Brimonidine was used. Hemostasis was assessed indirectly using surgical duration, need for intraoperative IOP elevation, infusion fluid quantity, instrument exchanges and surgeon-rated ease of surgery.
Results- 
Each group had 20 patients. Bonferroni analysis showed that Group D had shortest surgical duration, the least need for IOP elevation and best surgical ease. Infusion fluid use and instrument exchanges were lowest in Group B and D respectively. 
Conclusion-
Preoperative 0.1% Brimonidine is a safe and effective strategy to improve intraoperative hemostasis during diabetic vitrectomy, particularly when combined with intravitreal antiVEGF.

Membership No Author Name Email Mobile
1721 Dr.Rajesh Ramanjulu drragraj@gmail.com 9036952706